Journal of Traditional Chinese Medicine ›› 2026, Vol. 46 ›› Issue (3): 674-683.DOI: 10.19852/j.cnki.jtcm.2026.03.009
• Original Articles • Previous Articles Next Articles
WANG Xin1, CAO Xue1, QIN Yuning1, SUN Minglin1, YUE Lihong1, TIAN Yukun1, WANG Guangjun2, LIU Xinglong3, WANG Zirong4, Labasangzhu 5,6(
), LIU Jia1(
)
Received:2025-01-22
Accepted:2025-09-12
Online:2026-06-15
Published:2026-06-08
Contact:
Prof. LIU Jia, Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medicine Sciences, Beijing 100700, China. marie_liujia@sina.cn;Supported by:WANG Xin, CAO Xue, QIN Yuning, SUN Minglin, YUE Lihong, TIAN Yukun, WANG Guangjun, LIU Xinglong, WANG Zirong, Labasangzhu , LIU Jia. Effect of electro-thumbtack needles on symptoms during high-altitude exposure: a pilot, single-blind, randomized, controlled study[J]. Journal of Traditional Chinese Medicine, 2026, 46(3): 674-683.
| Variable | Total (n = 125) | ETN (n = 59) | SA(n = 66) | P value |
|---|---|---|---|---|
| Age (years, | 20.6±3.1 | 20.6±3.7 | 20.6±2.4 | 0.93 |
| Sex [n (%)] | 0.57 | |||
| Female | 31 (24.80) | 16 (27.12) | 15 (22.73) | |
| Male | 94 (75.20) | 43 (72.88) | 51 (77.27) | |
| Hight (cm, | 172.0±7.7 | 172.2±7.8 | 171.79±7.8 | 0.77 |
| Weight (kg, | 66.9±12.0 | 65.1±12.0 | 68.48±11.9 | 0.12 |
| BMI (kg/m2, | 22.6±3.6 | 21.9±3.5 | 23.19±3.6 | 0.05a |
| SBP (mm Hg, | 120.3±14.2 | 118.5±12.5 | 121.92±15.4 | 0.77 |
| DBP (mm Hg, | 84.8±9.6 | 83.5±9.3 | 86.0±9.8 | 0.15 |
| HR (bpm, | 103.7±15.2 | 104.0±13.5 | 103.6±16.7 | 0.90 |
| SpO2 (%, | 88.8±4.9 | 89.9±3.4 | 88.5±5.9 | 0.50 |
| ScO2 (%, | 64.3±4.2 | 63.1±4.8 | 65.4±3.2 | 0.00a |
| Transportation [n (%)] | 0.64 | |||
| Plane | 51 (40.80) | 22 (37.29) | 29 (43.94) | |
| Train/ Car | 74 (59.20) | 39 (62.71) | 37 (56.06) | |
| LLS (points, | 2.2±1.8 | 2.3±2.0 | 2.1±1.7 | 0.57 |
| AMS [n (%)] | 47 (37.60) | 25 (42.37) | 22 (33.33) | 0.30 |
| AMS >5 [n (%)] | 5 (4.0) | 4 (6.7) | 1 (1.5) | 0.43 |
| Prevention medication history [n (%)] | 0.27 | |||
| Yes | 57 (45.60) | 30 (50.85) | 27 (40.91) | |
| No | 68 (54.40) | 29 (49.15) | 39 (59.09) | |
| GSQS [Me (Q1, Q3)] | 5.0 (2.0, 9.0) | 5.0 (2.0, 9.0) | 5.0 (2.0, 9.0) | 0.26 |
| SSS [Me (Q1, Q3)] | 2.0 (2.0, 3.0) | 2.0 (2.0, 3.0) | 2.0 (2.0, 3.0) | 0.84 |
| 1.0 (0.0, 1.0) | 1.0 (0.0, 1.0) | 1.0 (0.0, 1.0) | 0.53 | |
| CFS [Me (Q1, Q3)] | 1.0 (0.0, 1.0) | 1.0 (0.0, 1.0) | 1.0 (0.0, 1.0) | 0.79 |
| Cortisol (pg/mL, | 1218.8±432.9 | 1286.9±362.4 | 1178.5±471.7 | 0.43 |
Table 1 Baseline participants’ characteristics in the full analysis set
| Variable | Total (n = 125) | ETN (n = 59) | SA(n = 66) | P value |
|---|---|---|---|---|
| Age (years, | 20.6±3.1 | 20.6±3.7 | 20.6±2.4 | 0.93 |
| Sex [n (%)] | 0.57 | |||
| Female | 31 (24.80) | 16 (27.12) | 15 (22.73) | |
| Male | 94 (75.20) | 43 (72.88) | 51 (77.27) | |
| Hight (cm, | 172.0±7.7 | 172.2±7.8 | 171.79±7.8 | 0.77 |
| Weight (kg, | 66.9±12.0 | 65.1±12.0 | 68.48±11.9 | 0.12 |
| BMI (kg/m2, | 22.6±3.6 | 21.9±3.5 | 23.19±3.6 | 0.05a |
| SBP (mm Hg, | 120.3±14.2 | 118.5±12.5 | 121.92±15.4 | 0.77 |
| DBP (mm Hg, | 84.8±9.6 | 83.5±9.3 | 86.0±9.8 | 0.15 |
| HR (bpm, | 103.7±15.2 | 104.0±13.5 | 103.6±16.7 | 0.90 |
| SpO2 (%, | 88.8±4.9 | 89.9±3.4 | 88.5±5.9 | 0.50 |
| ScO2 (%, | 64.3±4.2 | 63.1±4.8 | 65.4±3.2 | 0.00a |
| Transportation [n (%)] | 0.64 | |||
| Plane | 51 (40.80) | 22 (37.29) | 29 (43.94) | |
| Train/ Car | 74 (59.20) | 39 (62.71) | 37 (56.06) | |
| LLS (points, | 2.2±1.8 | 2.3±2.0 | 2.1±1.7 | 0.57 |
| AMS [n (%)] | 47 (37.60) | 25 (42.37) | 22 (33.33) | 0.30 |
| AMS >5 [n (%)] | 5 (4.0) | 4 (6.7) | 1 (1.5) | 0.43 |
| Prevention medication history [n (%)] | 0.27 | |||
| Yes | 57 (45.60) | 30 (50.85) | 27 (40.91) | |
| No | 68 (54.40) | 29 (49.15) | 39 (59.09) | |
| GSQS [Me (Q1, Q3)] | 5.0 (2.0, 9.0) | 5.0 (2.0, 9.0) | 5.0 (2.0, 9.0) | 0.26 |
| SSS [Me (Q1, Q3)] | 2.0 (2.0, 3.0) | 2.0 (2.0, 3.0) | 2.0 (2.0, 3.0) | 0.84 |
| 1.0 (0.0, 1.0) | 1.0 (0.0, 1.0) | 1.0 (0.0, 1.0) | 0.53 | |
| CFS [Me (Q1, Q3)] | 1.0 (0.0, 1.0) | 1.0 (0.0, 1.0) | 1.0 (0.0, 1.0) | 0.79 |
| Cortisol (pg/mL, | 1218.8±432.9 | 1286.9±362.4 | 1178.5±471.7 | 0.43 |
| Group | Baseline | 6 hd | 24 h | 48 h | 72h | 120 h | 168 h | Wald | P value | |
|---|---|---|---|---|---|---|---|---|---|---|
| ETN (n = 59) | 2.31 (1.95) | 1.64 (1.67) | 1.46 (1.58) | 1.20 (1.39) | 1.05 (1.38) | 0.73 (1.19) | 0.54 (1.01) | 51.7 | <0.001k | |
| SA (n = 66) | 2.12 (1.70) | 2.18 (1.81) | 1.56 (1.69) | 1.33 (1.47) | 1.12 (1.39) | 0.74 (1.21) | 0.42 (0.82) | 77.3 | <0.001l | |
| Adjusted Me D or Me D, 95% CI | 0.56a (-0.46,0.83) | 0.56 (0.01,1.11) | 0.13 (-0.36,0.61) | 0.15 (-0.28,0.59) | 0.09 (-0.35,0.54) | 0.05 (-0.35,0.46) | -0.10 (-0.44,0.25) | |||
| Wald | 0.56b | 4.01 | 0.26 | 0.47 | 0.17 | 0.07 | 0.30 | |||
| P value | 0.57c | 0.05e | 0.61f | 0.49g | 0.69h | 0.80i | 0.582j | |||
Table 2 LLS at different timepoints postintervention (points)
| Group | Baseline | 6 hd | 24 h | 48 h | 72h | 120 h | 168 h | Wald | P value | |
|---|---|---|---|---|---|---|---|---|---|---|
| ETN (n = 59) | 2.31 (1.95) | 1.64 (1.67) | 1.46 (1.58) | 1.20 (1.39) | 1.05 (1.38) | 0.73 (1.19) | 0.54 (1.01) | 51.7 | <0.001k | |
| SA (n = 66) | 2.12 (1.70) | 2.18 (1.81) | 1.56 (1.69) | 1.33 (1.47) | 1.12 (1.39) | 0.74 (1.21) | 0.42 (0.82) | 77.3 | <0.001l | |
| Adjusted Me D or Me D, 95% CI | 0.56a (-0.46,0.83) | 0.56 (0.01,1.11) | 0.13 (-0.36,0.61) | 0.15 (-0.28,0.59) | 0.09 (-0.35,0.54) | 0.05 (-0.35,0.46) | -0.10 (-0.44,0.25) | |||
| Wald | 0.56b | 4.01 | 0.26 | 0.47 | 0.17 | 0.07 | 0.30 | |||
| P value | 0.57c | 0.05e | 0.61f | 0.49g | 0.69h | 0.80i | 0.582j | |||
Figure 2 Evaluated outcomes after the ETN and SA interventions A: D-LLS over time; B: VAS scores for headache over time; C: CFS over time; D: incidence of AMS over time; E: rate of asymptomatic participants (LLS = 0) over time. ETN: treated with electro-thumbtack needle; SA: treated with sham acupuncture. D-LLS: decline from baseline in Lake Louise Score. VAS: visual analog scale. CFS: clinical functioning scores. AMS: acute mountain sickness. LLS: Lake Louise Score. A-C: baseline data calculated using the t test, others calculated using a generalized estimating equation. Data were described as mean and standard deviation; D, F: calculated using the χ 2 test. Qualitative data were described as percentage. aP < 0.05, ETN (n = 59) compared with SA (n = 66).
| Outcome | ETN (n = 59) | SA (n = 66) | t/Z value | P value | 95% CI |
|---|---|---|---|---|---|
| d-SBP (mm Hg, | -0.7±9.3 | 0.3±11.5 | -0.51 | 0.61 | -4.63, 2.71 |
| d-DBP (mm Hg, | 2.7±8.6 | 3.5±7.9 | -0.55 | 0.59 | -3.73, 2.12 |
| d-HR (bpm, | 5.9±11.8 | 3.1±15.9 | 1.11 | 0.27 | -2.22, 7.77 |
| d-SpO2 (%, | 0.0±5.3 | 1.5±6.3 | -1.39 | 0.17 | -3.50, 0.59 |
| d-ScO2 (%, | 0.9±5.4 | -1.0±5.0 | 2.10 | 0.04a | 0.10, 3.78 |
| d-GSQS [points, Me (Q1, Q3)] | 1.00 (0.00, 5.00) | 2.00 (0.00, 6.00) | -0.83 | 0.41 | 0.39, 0.41 |
| d-SSS [points, Me (Q1, Q3)] | 0.00(0.00, 1.00) | 0.00 (0.00, 1.00) | -0.31 | 0.76 | 0.75, 0.77 |
| d-VAS [points, Me (Q1, Q3)] | 0.00 (0.00, 1.00) | 0.00 (0.00, 1.00) | -1.06 | 0.30 | 0.29, 0.31 |
| d-CFS [points, Me (Q1, Q3)] | 0.00 (0.00, 0.00) | 0.00 (0.00, 0.00) | -0.16 | 0.88 | 0.87, 0.89 |
| Cortisol (pg/mL, | 985.3±361.5 | 1193.1±465.3 | -1.53 | 0.13 | -482.00, 66.22 |
Table 3 Secondary outcomes in the participants 48 h postintervention
| Outcome | ETN (n = 59) | SA (n = 66) | t/Z value | P value | 95% CI |
|---|---|---|---|---|---|
| d-SBP (mm Hg, | -0.7±9.3 | 0.3±11.5 | -0.51 | 0.61 | -4.63, 2.71 |
| d-DBP (mm Hg, | 2.7±8.6 | 3.5±7.9 | -0.55 | 0.59 | -3.73, 2.12 |
| d-HR (bpm, | 5.9±11.8 | 3.1±15.9 | 1.11 | 0.27 | -2.22, 7.77 |
| d-SpO2 (%, | 0.0±5.3 | 1.5±6.3 | -1.39 | 0.17 | -3.50, 0.59 |
| d-ScO2 (%, | 0.9±5.4 | -1.0±5.0 | 2.10 | 0.04a | 0.10, 3.78 |
| d-GSQS [points, Me (Q1, Q3)] | 1.00 (0.00, 5.00) | 2.00 (0.00, 6.00) | -0.83 | 0.41 | 0.39, 0.41 |
| d-SSS [points, Me (Q1, Q3)] | 0.00(0.00, 1.00) | 0.00 (0.00, 1.00) | -0.31 | 0.76 | 0.75, 0.77 |
| d-VAS [points, Me (Q1, Q3)] | 0.00 (0.00, 1.00) | 0.00 (0.00, 1.00) | -1.06 | 0.30 | 0.29, 0.31 |
| d-CFS [points, Me (Q1, Q3)] | 0.00 (0.00, 0.00) | 0.00 (0.00, 0.00) | -0.16 | 0.88 | 0.87, 0.89 |
| Cortisol (pg/mL, | 985.3±361.5 | 1193.1±465.3 | -1.53 | 0.13 | -482.00, 66.22 |
| 1. |
Trammer RA, Rooney D, Benderoth S, Wittkowski M, Wenzel J, Elmenhorst EM. Effects of moderate alcohol consumption and hypobaric hypoxia: implications for passengers' sleep, oxygen saturation and heart rate on long-haul flights. Thorax 2024; 79: 970-8.
DOI PMID |
| 2. |
Champigneulle B, Brugniaux JV, Stauffer E, et al. Expedition 5300: limits of human adaptations in the highest city in the world. J Physiol 2024; 602: 5449-62.
DOI URL |
| 3. | Titz A, Schneider S, Mueller J, Mayer L, Lichtblau M, Ulrich S. Symposium review: high altitude travel with pulmonary vascular disease. J Physiol 2024; 602: 5505-13. |
| 4. |
Farahani AA, Shahali H. Recurrent unilateral pupillary dilation and transient visual blurring: a clinical challenge during hypoxia exposure in a male fighter pilot. Med J Armed Forces India 2023; 79: S337-337S342.
DOI URL |
| 5. |
Crawford JE, Amaru R, Song J, et al. Natural selection on genes related to cardiovascular health in high-altitude adapted andeans. Am J Hum Genet 2017; 101: 752-67.
DOI PMID |
| 6. | Lamichhane S, Ghimire I, Pokhrel A, Sharma NR, Acharya SK. High-altitude illness: menace in himalayas of nepal. Ann Med Surg (Lond) 2022; 81: 104494. |
| 7. |
Roach RC, Hackett PH, Oelz O, et al. The 2018 lake louise acute mountain sickness score. High Alt Med Biol 2018; 19: 4-6.
DOI PMID |
| 8. | Berger MM, Hüsing A, Niessen N, et al. Prevalence and knowledge about acute mountain sickness in the Western Alps. PLoS One 2023; 18: e0291060. |
| 9. | Hall DP, MacCormick IJ, Phythian-Adams AT, et al. Network analysis reveals distinct clinical syndromes underlying acute mountain sickness. PLoS One 2014; 9: e81229. |
| 10. | Burtscher J, Swenson ER, Hackett PH, Millet GP, Burtscher M. Flying to high-altitude destinations: is the risk of acute mountain sickness greater. J Travel Med 2023; 30: taad011. |
| 11. |
Shen Y, Yang YQ, Liu C, et al. Association between physiological responses after exercise at low altitude and acute mountain sickness upon ascent is sex-dependent. Mil Med Res 2020; 7: 53.
DOI PMID |
| 12. | Hou YP, Wu JL, Tan C, Chen Y, Guo R, Luo YJ. Sex-based differences in the prevalence of acute mountain sickness: a Meta-analysis. Mil Med Res 2019; 6: 38. |
| 13. | Luks AM, Beidleman BA, Freer L, et al. Wilderness medical society clinical practice guidelines for the prevention, diagnosis, and treatment of acute altitude illness: 2024 update. Wilderness Environ Med 2024; 35: 2S-19S. |
| 14. |
Gao D, Wang Y, Zhang R, Zhang Y. Efficacy of acetazolamide for the prophylaxis of acute mountain sickness: a systematic review, Meta-analysis and trial sequential analysis of randomized clinical trials. Am J Med Sci 2021; 361: 635-45.
DOI URL |
| 15. | Chen Y, Guo D. Comparative study of acupuncture-moxibustion and transcranial micro-current stimulation in therapy of altitude hypoxia headache and insomnia. In: Long S, Dhillon BS, editors. Man-Machine-Environment System Engineering. MMESE 2019: Proceedings of the 19th International Conference on Man-Machine-Environment System Engineering; 2019 Oct 19-21; Shanghai, China. Singapore: Springer, 2020: 11-20. |
| 16. |
Zheng H, Chen M, Wu X, Li Y, Liang FR. Manage migraine with acupuncture: a review of acupuncture protocols in randomized controlled trials. Am J Chin Med 2010; 38: 639-50.
DOI URL |
| 17. | Kim HS, Kim YJ, Lee HJ, et al. Development and validation of acupuncture fear scale. Evid Based Complement Alternat Med 2013; 2013: 109704. |
| 18. |
Lee IS, Jo HJ, Lee SH, et al. Fear of acupuncture enhances sympathetic activation to acupuncture stimulation. Acupunct Med 2013; 31: 276-81.
DOI URL |
| 19. |
Zhao W, Li J, Wang Y, et al. Efficacy and safety of the "Xingnao Kaiqiao" acupuncture technique via intradermal needling to treat postoperative gastrointestinal dysfunction of laparoscopic surgery: study protocol for a randomized controlled trial. Trials 2017; 18: 567.
DOI URL |
| 20. | Hu H, Yuan Z, Han L, Li T, Song F. Intradermal needling and acupuncture in prevention and treatment of leukopenia after chemotherapy with spleen-kidney deficiency: a randomized controlled trial. Zhong Guo Zhen Jiu 2024; 44: 631-6. |
| 21. | Li Q. Clinical study on the treatment of perimenopausal insomnia with a new type of thumbtack-needles. Sichuan Zhong Yi 2017; 35: 202-4. |
| 22. |
Wang X, Wang G, Jia S, Labasangzhu L, Wang Z, Liu J. Safety and efficacy of electro-thumbtack needle for acute mountain sickness patients: a protocol of a randomized, single-blinded, and placebo-controlled study. BMC Complement Med Ther 2024; 24: 355.
DOI PMID |
| 23 | World Health Organization. WHO standard acupuncture point locations in the Western Pacific region. Regional Office for the Western Pacific, 2022-4-22, cited 2024-11-11; 249. Available from URL: https://iris.who.int/handle/10665/353407. |
| 24. |
Teare MD, Dimairo M, Shephard N, Hayman A, Whitehead A, Walters SJ. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials 2014; 15: 264.
DOI PMID |
| 25. |
Meshram I, Boiroju NK, Longvah T. Prevalence of overweight/obesity, hypertension and its associated factors among women from Northeast India. Indian Heart J 2022; 74: 56-62.
DOI URL |
| 26. |
Kornitzer M, Dramaix M, De Backer G. Epidemiology of risk factors for hypertension: implications for prevention and therapy. Drugs 1999; 57: 695-712.
PMID |
| 27. |
Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res 2002; 53: 688-708.
DOI PMID |
| 28. |
Hou Y, Liang H, Fan C, Liu R, Feng Y. Transcutaneous electrical acupoint stimulation to prevent dizziness after microvascular decompression for hemifacial spasm: a randomized controlled trial. Complement Ther Med 2024; 83: 103055.
DOI URL |
| 29. | AlAteeq MA, Alghaihab MM, Marghlani LK, Shamsaddin LA, Alghamdi RK, Alfadley MA. Comparing the prevalence of sleep disorders among underweight, normal, overweight, and obese adults in Riyadh, Saudi Arabia. Cureus 2024; 16: e58858. |
| 30. |
Bian SZ, Zhang L, Jin J, et al. The onset of sleep disturbances and their associations with anxiety after acute high-altitude exposure at 3700 m. Transl Psychiatry 2019; 9: 175.
DOI |
| 31. |
Zhang J, Tang S, Chen C, et al. A bibliometric analysis of the studies in high-altitude induced sleep disturbances and cognitive impairment research. Front Physiol 2023; 14: 1133059.
DOI URL |
| 32. | Xu Y, Xu X, Yang Z, Guo M, Jiang X. Effects of electroacupuncture at "Shuigou" (GV 26) on the expressions of soluble guanylate cyclase and protein kinase G in the cerebral artery vascular smooth muscle of rats with cerebral infarction. Zhen Ci Yan Jiu 2020; 45: 789-92+805. |
| 33. |
Tao QF, Huang YB, Yuan L, et al. Acupuncture versus tricyclic antidepressants in the prophylactic treatment of tension-type headaches: an indirect treatment comparison Meta-analysis. J Headache Pain 2024; 25: 67.
DOI |
| 34. |
Wu XK, Gao JS, Ma HL, et al. Acupuncture and doxylamine-pyridoxine for nausea and vomiting in pregnancy: a randomized, controlled, 2 × 2 factorial trial. Ann Intern Med 2023; 176: 922-33.
DOI URL |
| 35. | Hu L, Wei Z, Wang X, Wu W. Transcranial magnetic stimulation in the assessment of acupuncture effect on exercise-induced fatigue. Brain Behav 2024; 14: e3575. |
| 36. | Yin X, Li W, Liang T, et al. Effect of electroacupuncture on insomnia in patients with depression: a randomized clinical trial. JAMA Netw Open 2022; 5: e2220563. |
| 37. |
Gatterer H, Villafuerte FC, Ulrich S, Bhandari SS, Keyes LE, Burtscher M. Altitude illnesses. Nat Rev Dis Primers 2024; 10: 43.
DOI PMID |
| 38. |
Rattanawong W, Rapoport A, Srikiatkhachorn A, Neurobiology of migraine progression. Neurobiol Pain 2022; 12: 100094.
DOI URL |
| 39. | Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain. Neuron 2018; 100: 1292-311. |
| 40. |
Sudershan A, Younis M, Sudershan S, Kumar P. Migraine as an inflammatory disorder with microglial activation as a prime candidate. Neurol Res 2023; 45: 200-15.
DOI URL |
| 41. |
Zhang Z, Lu T, Li S, et al. Acupuncture extended the thrombolysis window by suppressing blood-brain barrier disruption and regulating autophagy-apoptosis balance after ischemic stroke. Brain Sci 2024; 14: 399.
DOI URL |
| 42. |
Chavez LM, Huang SS, MacDonald I, Lin JG, Lee YC, Chen YH. Mechanisms of acupuncture therapy in ischemic stroke rehabilitation: a literature review of basic studies. Int J Mol Sci 2017; 18: 2270.
DOI URL |
| 43. |
Wen CK, Lee TY. Electroacupuncture prevents white adipose tissue inflammation through modulation of hypoxia-inducible factors-1α-dependent pathway in obese mice. BMC Complement Altern Med 2015; 15: 452.
DOI URL |
| 44. |
Wang C, Li MX, Li YD, Li YP. Bloodletting acupuncture at Jing-well points alleviates myocardial injury in acute altitude hypoxic rats by activating HIF-1α/BNIP3 signaling-mediated mitochondrial autophagy and decreasing oxidative stress. Chin J Integr Med 2023; 29: 170-8.
DOI |
| 45. |
Cui S, Wang K, Wu SB, et al. Electroacupuncture modulates the activity of the hippocampus-nucleus tractus solitarius-vagus nerve pathway to reduce myocardial ischemic injury. Neural Regen Res 2018; 13: 1609-18.
DOI PMID |
| 46. |
Li N, Guo Y, Gong Y, et al. The anti-inflammatory actions and mechanisms of acupuncture from acupoint to target organs via neuro-immune regulation. J Inflamm Res 2021; 14: 7191-224.
DOI URL |
| 47. |
Fan AY. Anti-inflammatory mechanism of electroacupuncture involves the modulation of multiple systems, levels and targets and is not limited to "driving the vagus-adrenal axis". J Integr Med 2023; 21: 320-3.
DOI URL |
| 48. |
Pecchio O, Martinelli M, Lupi G, et al. Acupuncture effects on cerebral blood flow during normoxia and normobaric hypoxia: results from a prospective crossover pilot study. Technologies 2021; 9: 102.
DOI URL |
| 49. |
Amini Rarani S, Rajai N, Sharififar S. Effects of acupressure at the P6 and LI4 points on the anxiety level of soldiers in the Iranian military. BMJ Mil Health 2021; 167: 177-81.
DOI PMID |
| 50. |
Najafi F, Jaafarpour M, Sayehmiri K, Khajavikhan J. An Evaluation of acupressure on the Sanyinjiao (SP6) and Hugo (LI4) points on the pain severity and length of labor: a systematic review and Meta-analysis study. Iran J Nurs Midwifery Res 2018; 23: 1-7.
DOI PMID |
| 51. |
Wang H, Liu WJ, Shen GM, Zhang MT, Huang S, He Y. Neural mechanism of gastric motility regulation by electroacupuncture at RN12 and BL21: a paraventricular hypothalamic nucleus-dorsal vagal complex-vagus nerve-gastric channel pathway. World J Gastroenterol 2015; 21: 13480-9.
DOI URL |
| 52. |
Small E, Goldberg E, Musi M, et al. Prochlorperazine maleate versus placebo for the prevention of acute mountain sickness: study protocol for a randomized controlled trial. Trials 2024; 25: 785.
DOI PMID |
| 53. |
Schober A, Chinn G, Eichbaum Y, Dudley M, Sall JW; University of California San Francisco AR36 working group. A randomized phase 2 study to evaluate efficacy and safety of AR36 for prevention of acute mountain sickness. Wilderness Environ Med 2023; 34: 498-508.
DOI PMID |
| 54. |
Imray C, Wright A, Subudhi A, Roach R. Acute mountain sickness: pathophysiology, prevention, and treatment. Prog Cardiovasc Dis 2010; 52: 467-84.
DOI PMID |
| 55. | Zubieta-Calleja G. Redefining chronic mountain sickness: insights from high-altitude research and clinical experience. Med Rev (2021) 2024; 5: 44-65. |
| [1] | LU Xiaoxiao, XU Yipeng, ZHOU Minjie, ZHANG Chengshun, CAI Dingjun, ZHAO Zhengyu. Role of gamma-aminobutyric acid-ergic neurons in the thalamic reticular nucleus in regulating sleep-wake cycles in mice treated with acupuncture for insomnia [J]. Journal of Traditional Chinese Medicine, 2026, 46(3): 552-560. |
| [2] | QU Yuanyuan, FENG Chuwen, SUN Weibo, SHAO Yuying, LU Jing, GUO Shuhao, LI Binbin, YANG Tiansong. Effect of “Tongdu Yupi Tiaoshen” electroacupuncture on behavioral performance and hippocampal structure and function in chronic fatigue syndrome rats [J]. Journal of Traditional Chinese Medicine, 2026, 46(3): 605-616. |
| [3] | LIU Na, CHEN Zhimin, ZHAO Gang, YUAN Bin, HUANG Zhijun, ZHANG Xuerong, SONG Guihua, CHEN Huafang. Efficacy and safety of the Chinese herbal medicine Xiao’er Niuhuang antipyretic plaster (小儿牛黄退热贴膏) for treating fever in children with acute upper respiratory tract infection with wind-heat syndrome: a multicenter, randomized, double-blind, controlled clinical trial [J]. Journal of Traditional Chinese Medicine, 2026, 46(3): 666-673. |
| [4] | SONG Ying, YOU Yalin, LIAO Yiru, HU Luodan, WANG Danna, NIE Guangning. Cheek acupuncture therapy combined with Chinese herbal medicine for female chronic pelvic pain: a retrospective study [J]. Journal of Traditional Chinese Medicine, 2026, 46(3): 726-732. |
| [5] | JIAN Jiawei, DING Zhimin, ZHUANG Yueyang, WANG Junzi, YANG Minguang, LIU Weilin. Acupuncture-driven exosomes: an emerging therapy [J]. Journal of Traditional Chinese Medicine, 2026, 46(3): 768-778. |
| [6] | ZHUANG Zifeng, WO Choying, CHEN Hongling, XIE Hailiang, ZHAO Canghuan, ZHANG Di, QING Peng. Acupuncture inhibits astrocytic hyperactivation via the p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1 signaling pathway in cerebral ischemia-reperfusion injury [J]. Journal of Traditional Chinese Medicine, 2026, 46(2): 316-325. |
| [7] | HU Wenyue, ZHONG Biying, WANG Zhenyi, ZHANG Meng, CHANG Ze, TAN Xi, HAN Zhenyun. Efficacy of Traditional Chinese Medicine psychosomatic integration therapy for subthreshold depression: a multicenter randomized controlled trial [J]. Journal of Traditional Chinese Medicine, 2026, 46(2): 392-400. |
| [8] | LI Shuning, LIU Hongxu, LAI Xiaolei, SHANG Juju, XING Wenlong, ZHANG Heyi. Efficacy and safety of Yi’anning pills (益安宁丸) for stable angina pectoris in coronary heart disease with Qi-blood and liver-kidney deficiency syndrome: a multicenter, randomized, double-blind, superiority clinical trial [J]. Journal of Traditional Chinese Medicine, 2026, 46(2): 401-410. |
| [9] | LI Yuejie, YANG Guang, LIU Luping, YANG Jingwen, LIU Cunzhi. Impact of body mass index on the efficacy of acupuncture treatment of postprandial distress syndrome: secondary analysis of a randomized clinical trial [J]. Journal of Traditional Chinese Medicine, 2026, 46(2): 439-446. |
| [10] | LIN Lixia, LI Xin, LI Ling, YANG Pu, LU Liming, LIU Buping, SU Shengyong. Multiple acupuncture and moxibustion therapies for allergic rhinitis in adults: a network Meta-analysis of randomized controlled trials [J]. Journal of Traditional Chinese Medicine, 2026, 46(1): 1-13. |
| [11] | XU Huanfang, LI Jiashan, YANG Li, WU Wenzhong, YANG Jun, ZHANG Wei, LI Hui, QU Nini, WANG Rui, WANG Landi, YANG Hongzhi, ZHANG Lihua, HE Yong, XIONG Guanyu, LIU Baoyan, FANG Yigong. Effect of point application therapy for bronchial asthma: a multicenter randomized controlled trial [J]. Journal of Traditional Chinese Medicine, 2026, 46(1): 195-204. |
| [12] | YUAN Menghua, SHAO Jianbin, YANG Yawei, ZHAO Yan, HU Xingang. Combined acupuncture and herb treatment improves intestinal flora inabdominally obese subjects based on 16s rRNA sequencing: a randomized controlled trial [J]. Journal of Traditional Chinese Medicine, 2026, 46(1): 205-210. |
| [13] | WANG Ci, CAO Yawen, WANG Jiaying, CHEN Jixin, MA Xue, WANG Xianliang, MAO Jingyuan. Efficacy and safety of acupuncture for arrythmias: an overview of systematic reviews and Meta-analyses [J]. Journal of Traditional Chinese Medicine, 2025, 45(6): 1178-1190. |
| [14] | SHOU Yin, JIANG Juntao, HU Jianlin, JI Wei, CHEN Chunyan, HU Li, MA Yuhang, ZHANG Bimeng. Electroacupuncture alleviates type 2 diabetes mellitus by promoting plasma-derived exosomal circular RNA of enhancer of zeste homolog 1 expression [J]. Journal of Traditional Chinese Medicine, 2025, 45(6): 1228-1237. |
| [15] | LIU Jingxuan, MO Qian, LEI Guowu, JIA Yejuan, LI Aiying, JIA Chunsheng, PAN Lijia. Four-dimensional data independent acquisition proteomics and metabolomics reveal mechanisms of hydrogen-rich water at Zusanli (ST36) point against triple-negative breast cancer in mice [J]. Journal of Traditional Chinese Medicine, 2025, 45(6): 1238-1253. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
Sponsored by China Association of Chinese Medicine
& China Academy of Chinese Medical Sciences
16 Nanxiaojie, Dongzhimen Nei, Beijing, China. 100700 Email: jtcmen@126.com
Copyright 2020 Journal of Traditional Chinese Medicine. All rights reserved.
